CC
COLL icon

Centiva Capital’s Collegium Pharmaceutical COLL Stock Holding History

Centiva Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,289
Closed -$334K – 1208
2025
Q2 		$334K Buy
+11,289
New +$322K 0.01% 1153
2025
Q1 		– Sell
-10,727
Closed -$307K – 1623
2024
Q4 		$307K Buy
+10,727
New +$355K 0.01% 1119
2024
Q3 		– Sell
-24,568
Closed -$791K – 2213
2024
Q2 		$791K Buy
24,568
+13,100
+114% +$454K 0.01% 900
2024
Q1 		$445K Buy
11,468
+4,559
+66% +$160K 0.01% 1043
2023
Q4 		$213K Buy
+6,909
New +$173K 0.01% 1395

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Centiva Capital's COLL Position: Q3 2025 in Review

Centiva Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2025, closing a stake of 11,289 shares — an estimated $334K sold.

Centiva Capital first reported a position in COLL in Q4 2023 and held it in 5 quarters. The position peaked at $791K in Q2 2024. 244 funds tracked by Wall St. Rank hold COLL as of Q3 2025.

  • Centiva Capital reported no remaining Collegium Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 11,289 Collegium Pharmaceutical shares in Q3 2025, an estimated $334K.
  • Centiva Capital first reported a position in Collegium Pharmaceutical in Q4 2023 and held it in 5 quarters.
  • Centiva Capital's Collegium Pharmaceutical position peaked at $791K in Q2 2024.
  • 244 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.